U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H21NO4
Molecular Weight 327.3743
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NALOXONE

SMILES

[H][C@@]12OC3=C4C(C[C@H]5N(CC=C)CC[C@@]14[C@@]5(O)CCC2=O)=CC=C3O

InChI

InChIKey=UZHSEJADLWPNLE-GRGSLBFTSA-N
InChI=1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19-/m1/s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
NALOXONE
EMA EPAR   HSDB   INN   MI   ORANGE BOOK   USP-RS   VANDF   WHO-DD  
INN  
Official Name English
17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE
Common Name English
NALOXONE [MI]
Common Name English
DBL NALOXONE
Brand Name English
Naloxone [WHO-DD]
Common Name English
(-)-N-ALLYL-14-HYDROXYNORDIHYDROMORPHINONE
Common Name English
MORPHINAN-6-ONE, 4,5-EPOXY-3,14-DIHYDROXY-17-(2-PROPENYL)-
Systematic Name English
NALOXONE [VANDF]
Common Name English
NALOXONE [USP-RS]
Common Name English
NALOXONE [EMA EPAR]
Common Name English
NSC-70413
Code English
naloxone [INN]
Common Name English
NALOXONE [ORANGE BOOK]
Common Name English
NALOXONE [HSDB]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 280209
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
WHO-ESSENTIAL MEDICINES LIST 4.2
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
NDF-RT N0000000154
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
EMA ASSESSMENT REPORTS SUBOXONE (AUTHORIZED: OPIOID-RELATED DISEASES)
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
WHO-VATC QV03AB15
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
FDA ORPHAN DRUG 79093
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
WHO-ATC V03AB15
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
WHO-ATC A06AH04
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
LIVERTOX NBK548244
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
NDF-RT N0000175691
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
WHO-ATC N02AA53
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
NCI_THESAURUS C681
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
Code System Code Type Description
ChEMBL
CHEMBL80
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
LACTMED
Naloxone
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
CHEBI
7459
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
PUBCHEM
5284596
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
SMS_ID
100000085468
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
WIKIPEDIA
NALOXONE
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
DRUG CENTRAL
1878
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
RXCUI
7242
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY RxNorm
DAILYMED
36B82AMQ7N
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
EVMPD
SUB09142MIG
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
INN
1526
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
EPA CompTox
DTXSID8023349
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
MESH
D009270
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
FDA UNII
36B82AMQ7N
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
DRUG BANK
DB01183
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
NCI_THESAURUS
C62054
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
RS_ITEM_NUM
1453005
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
IUPHAR
1638
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
HSDB
3279
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
ECHA (EC/EINECS)
207-365-7
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
NSC
70413
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
MERCK INDEX
m7717
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY Merck Index
CAS
465-65-6
Created by admin on Fri Dec 15 15:12:56 UTC 2023 , Edited by admin on Fri Dec 15 15:12:56 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of NALOXONE
METABOLITE (PARENT)
Structure of Noroxymorphone
METABOLITE (PARENT)
Structure of NALOXONE-3-GLUCURONIDE
METABOLITE (PARENT)
Structure of .ALPHA.-NALOXOL
SALT/SOLVATE (PARENT)
Structure of DINALOXONE PAMOATE
SALT/SOLVATE (PARENT)
Structure of NALOXONE HYDROCHLORIDE
SALT/SOLVATE (PARENT)
Structure of NALOXONE PAMOATE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966